Département de Physiologie, Groupe de Recherche sur le Système Nerveux Central, Université de Montréal, Montréal, QC H3T 1J4, Canada.
Eur J Neurosci. 2013 Jun;37(12):1925-30. doi: 10.1111/ejn.12251.
Alzheimer's disease, with its two most prominent pathological factors amyloid beta and tau protein, can be described as a disease of the synapse. It therefore comes as little surprise that NMDA receptor-related synaptic dysfunction had been thought for several years to underlie the synaptic pathophysiology seen in Alzheimer's disease. In this review I will summarise recent evidence showing that the NMDA receptor links the effects of extracellular amyloid beta with intracellular tau protein. Furthermore, the antagonistic roles of Fyn and STEP in NMDA receptor regulation, synaptic plasticity and induction of synaptic depression will be discussed.
阿尔茨海默病的两个最主要的病理因素是淀粉样β蛋白和tau 蛋白,可以将其描述为一种突触疾病。因此,多年来人们一直认为,NMDA 受体相关的突触功能障碍是阿尔茨海默病中所见突触病理生理学的基础,这并不奇怪。在这篇综述中,我将总结最近的证据,表明 NMDA 受体将细胞外淀粉样β蛋白的作用与细胞内 tau 蛋白联系起来。此外,还将讨论 Fyn 和 STEP 在 NMDA 受体调节、突触可塑性和诱导突触抑制中的拮抗作用。